2,339
Views
14
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: RADIOTHERAPY AND RADIOOPHYSICS

Mixed-beam approach in locally advanced nasopharyngeal carcinoma: IMRT followed by proton therapy boost versus IMRT-only. Evaluation of toxicity and efficacy

, , , , ORCID Icon, , , , , , ORCID Icon, , , , , , , , , , , , & show all
Pages 541-548 | Received 08 Feb 2019, Accepted 11 Feb 2020, Published online: 23 Feb 2020

References

  • Co J, Mejia MB, Dizon JM. Evidence on effectiveness of intensity-modulated radiotherapy versus 2-dimensional radiotherapy in the treatment of nasopharyngeal carcinoma: meta-analysis and a systematic review of the literature. Head Neck. 2016;38(Suppl. 1):E2130–E2142.
  • Chan AT, Leung SF, Ngan RK, et al. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst. 2005;97(7):536–539.
  • Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol. 1998;16(4):1310–1317.
  • Peng G, Wang T, Yang KY, et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol. 2012;104(3):286–293.
  • Tonoli S, Alterio D, Caspiani O, et al. Nasopharyngeal carcinoma in a low incidence European area: a prospective observational analysis from the Head and Neck Study Group of the Italian Society of Radiation Oncology (AIRO). Strahlenther Onkol. 2016;192(12):931–943.
  • Orlandi E, Tomatis S, Potepan P, et al. Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma. Fut Oncol (London, England). 2013;9(1):103–114.
  • Blanchard P, Gunn GB, Lin A, et al. Proton therapy for head and neck cancers. Semin Radiat Oncol. 2018;28(1):53–63.
  • Mendenhall NP, Malyapa RS, Su Z, et al. Proton therapy for head and neck cancer: rationale, potential indications, practical considerations, and current clinical evidence. Acta Oncol (Stockholm, Sweden). 2011;50(6):763–771.
  • Doyen J, Bondiau PY, Benezery K, et al. Indications and results for protontherapy in cancer treatments. Cancer Radiother. 2016;20(6–7):513–518.
  • Fitzek MM, Thornton AF, Varvares M, et al. Neuroendocrine tumors of the sinonasal tract. Results of a prospective study incorporating chemotherapy, surgery, and combined proton-photon radiotherapy. Cancer. 2002;94(10):2623–2634.
  • Herr MW, Sethi RK, Meier JC, et al. Esthesioneuroblastoma: an update on the Massachusetts eye and ear infirmary and Massachusetts general hospital experience with craniofacial resection, proton beam radiation, and chemotherapy. J Neurol Surg B Skull Base. 2014;75(1):58–64.
  • Fukumitsu N, Okumura T, Mizumoto M, et al. Outcome of T4 (International Union Against Cancer Staging System, 7th edition) or recurrent nasal cavity and paranasal sinus carcinoma treated with proton beam. Int J Radiat Oncol Biol Phys. 2012;83(2):704–711.
  • Orecchia R, Zurlo A, Loasses A, et al. Particle beam therapy (hadrontherapy): basis for interest and clinical experience. Eur J Cancer (Oxford, England). 1998;34(4):459–468.
  • Ramaekers BL, Pijls-Johannesma M, Joore MA, et al. Systematic review and meta-analysis of radiotherapy in various head and neck cancers: comparing photons, carbon-ions and protons. Cancer Treatment Rev. 2011;37(3):185–201.
  • Chan A, Adams J, Weyman E, et al. A phase II trial of proton radiation therapy with chemotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2012;84(3):S151–S152.
  • McDonald MW, Liu Y, Moore MG, et al. Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy. Radiat Oncol. 2016;11(1):32.
  • Chan A. A phase II study of proton radiotherapy with chemotherapy for nasopharyngeal carcinoma; 2008; [cited 2020 Mar 2]. Available from: https://clinicaltrials.gov/ct2/show/NCT00592501
  • Dagan R. A clinical outcomes protocol of photon/proton beam radiation therapy for carcinoma of the nasopharynx; 2008; [cited 2020 Mar 2]. Available from: https://clinicaltrials.gov/ct2/show/NCT00797290
  • CNAO. Phase II clinical study on proton therapy boost (hadrontherapy) for locally advanced head and neck tumors; 2017; [cited 2020 Mar 2]. Available from: https://clinicaltrials.gov/ct2/show/NCT03183271
  • Orecchia R, Vitolo V, Fiore MR, et al. Proton beam radiotherapy: report of the first ten patients treated at the “Centro Nazionale di Adroterapia Oncologica (CNAO)” for skull base and spine tumours. Radiol Med. 2014;119(4):277–282.
  • Brouwer CL, Steenbakkers RJ, Bourhis J, et al. CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. Radiother Oncol. 2015;117(1):83–90.
  • Merlotti A, Alterio D, Vigna-Taglianti R, et al. Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology – head and neck working group. Radiat Oncol. 2014;9(1):264.
  • Liang SB, Wang Y, Hu XF, et al. Survival and toxicities of IMRT based on the RTOG protocols in patients with nasopharyngeal carcinoma from the endemic regions of China. J Cancer. 2017;8(18):3718–3724.
  • Lin L, Yao JJ, Zhou GQ, et al. The efficacy and toxicity of individualized intensity-modulated radiotherapy based on the tumor extension patterns of nasopharyngeal carcinoma. Oncotarget. 2016;7(15):20680–20690.
  • Lewis GD, Holliday EB, Kocak-Uzel E, et al. Intensity-modulated proton therapy for nasopharyngeal carcinoma: decreased radiation dose to normal structures and encouraging clinical outcomes. Head Neck. 2016;38(Suppl. 1):E1886–E195.
  • Holliday EB, Garden AS, Rosenthal DI, et al. Proton therapy reduces treatment-related toxicities for patients with nasopharyngeal cancer: a case-match control study of intensity-modulated proton therapy and intensity-modulated photon therapy. Int J Part Ther. 2015;2(1):19–28.
  • Alterio D, Gerardi MA, Cella L, et al. Radiation-induced acute dysphagia: prospective observational study on 42 head and neck cancer patients. Strahlenther Onkol. 2017;193(11):971–981.
  • Ng WT, Lee MC, Chang AT, et al. The impact of dosimetric inadequacy on treatment outcome of nasopharyngeal carcinoma with IMRT. Oral Oncol. 2014;50(5):506–512.
  • Taheri-Kadkhoda Z, Bjork-Eriksson T, Nill S, et al. Intensity-modulated radiotherapy of nasopharyngeal carcinoma: a comparative treatment planning study of photons and protons. Radiat Oncol. 2008;3(1):4.
  • Widesott L, Pierelli A, Fiorino C, et al. Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation. Int J Radiat Oncol Biol Phys. 2008;72(2):589–596.
  • Olch AJ, Gerig L, Li H, et al. Dosimetric effects caused by couch tops and immobilization devices: report of AAPM Task Group 176. Med Phys. 2014;41(6 Pt 1):61501.
  • Malyapa R, Lowe M, Bolsi A, et al. Evaluation of robustness to setup and range uncertainties for head and neck patients treated with pencil beam scanning proton therapy. Int J Radiat Oncol Biol Phys. 2016;95(1):154–162.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.